IDUA and Scheie syndrome: Transduced cells are limited to the nasal epithelium and olfactory bulb after intranasal administration of rAAV9-Idua in an adult MPS I mouse model; however, accumulated pathogenic materials are reduced in the brain due to enzyme diffusion from transduced cells into the brain (Belur et al., 2017).